Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
一项前瞻性观察研究的中期分析显示,对癌症患者接种一剂与两剂新冠疫苗BNT162b2的安全性和免疫原性比较。
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(21)00213-8
Monin, Leticia; Laing, Adam G; Muñoz-Ruiz, Miguel; McKenzie, Duncan R; Del Molino Del Barrio, Irene; Alaguthurai, Thanussuyah; Domingo-Vila, Clara; Hayday, Thomas S; Graham, Carl; Seow, Jeffrey; Abdul-Jawad, Sultan; Kamdar, Shraddha; Harvey-Jones, Elizabeth; Graham, Rosalind; Cooper, Jack; Khan, Muhammad; Vidler, Jennifer; Kakkassery, Helen; Sinha, Shubhankar; Davis, Richard; Dupont, Liane; Francos Quijorna, Isaac; O'Brien-Gore, Charlotte; Lee, Puay Ling; Eum, Josephine; Conde Poole, Maria; Joseph, Magdalene; Davies, Daniel; Wu, Yin; Swampillai, Angela; North, Bernard V; Montes, Ana; Harries, Mark; Rigg, Anne; Spicer, James; Malim, Michael H; Fields, Paul; Patten, Piers; Di Rosa, Francesca; Papa, Sophie; Tree, Timothy; Doores, Katie J; Hayday, Adrian C; Irshad, Sheeba